AFT Pharmaceuticals - Growth in the face of a challenging environment
AFT Pharmaceuticals recently reported its results for FY21. Operating revenue grew strongly by 7% year-on-year to NZ$113.1m, driven mainly by 11%...
623 Views
AFT Pharmaceuticals: On Script With a New Deal
AFT PharmaceuticalsOn Script With a New Deal RESEARCH INSIGHTS AFT has ticked off another milestone with the signing of an agreement for...
481 Views
AFT Pharmaceuticals: Guidance Lowered; COVID Side Effects Linger
AFT PharmaceuticalsGuidance Lowered; COVID Side Effects Linger RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) materially downgraded its FY21 EBIT...
737 Views
AFT Pharmaceuticals: 1H21 Result —Under the Weather
AFT Pharmaceuticals1H21 Result —Under the Weather RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) reported 1H21 underlying growth of ~+9%, albeit...
654 Views
AFT Pharmaceuticals: Annual Meeting Check Up
AFT PharmaceuticalsAnnual Meeting Check Up RESEARCH INSIGHTS AFT Pharmaceuticals' (AFT) Annual Meeting saw FY21 guidance for strong profit growth...
181 Views